이 애플리케이션의 일부 콘텐츠는 현재 사용할 수 없습니다.
이 상황이 계속되면 다음 주소로 문의하십시오피드백 및 연락
1. (WO2018106645) β-1,6-GLUCAN THERAPEUTIC ANTIBODY CONJUGATES
국제사무국에 기록된 최신 서지정보    정보 제출

공개번호: WO/2018/106645 국제출원번호: PCT/US2017/064631
공개일: 14.06.2018 국제출원일: 05.12.2017
IPC:
A61K 39/395 (2006.01) ,A61K 47/61 (2017.01) ,A61P 35/00 (2006.01)
A SECTION A — 생활필수품 농업
61
위생학; 의학 또는 수의학
K
의약용, 치과용 또는 화장용 제제
39
항원 또는 항체를 함유한 의료품 제제
395
항체; 면역글로블린; 면역혈청, 예. 항림프구 혈청
[IPC code unknown for A61K 47/61]
A SECTION A — 생활필수품 농업
61
위생학; 의학 또는 수의학
P
화합물 또는 의약품 제제의 특정한 치료효과
35
항종양제
출원인:
INNATE BIOTHERAPEUTICS, LLC [US/US]; 16 Everett Street Newton, MA 02459, US
발명자:
REZNIK, Gabriel, Oscar; US
KANE, John, James; US
SIEDLECKI, James, Michael; US
DOSTALOVA, Zuzana; US
SANSAL-CASTELLANO, Isabelle; US
RUBIN-BEJERANO, Ifat; US
MIAO, Hua; US
FURFINE, Eric, Steven; US
대리인:
ABELLEIRA, Susan, M.; US
우선권 정보:
62/431,36207.12.2016US
발명의 명칭: (EN) β-1,6-GLUCAN THERAPEUTIC ANTIBODY CONJUGATES
(FR) CONJUGUÉS D'ANTICORPS THÉRAPEUTIQUE DE β-1,6-GLUCANE
요약서:
(EN) The present invention encompasses embodiments in which a therapeutic antibody is conjugated to β-1,6-glucan oligomers. Thus, the present invention includes, among other things, compositions including a therapeutic antibody conjugated to one or more β-1-,6-glucan oligomers. The present invention further includes, among other things, methods of making and/or using such β-1,6-glucan conjugates. In certain embodiments, a β-1,6-glucan conjugate of the present invention is useful as a therapeutic or in a method of therapy.
(FR) La présente invention concerne des modes de réalisation dans lesquels un anticorps thérapeutique est conujugué à des oligomères de β-1,6-glucane. Ainsi, la présente invention comprend, entre autres, des compositions comprenant un anticorps thérapeutique conjugué à un ou plusieurs oligomère(s) de β-1,6-glucane. La présente invention comprend également, entre autres, des méthodes permettant de fabriquer et/ou d'utiliser lesdits conjugués de β-1,6-glucane. Dans certains modes de réalisation, un conjugué de β-1,6-glucane de la présente invention est utilisable en tant qu'agent thérapeutique ou au sein d'une méthode de traitement.
지정국: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
아프리카지역 지식재산권기구(ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
유라시아 특허청 (AM, AZ, BY, KG, KZ, RU, TJ, TM)
유럽 특허청(EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
공개언어: 영어 (EN)
출원언어: 영어 (EN)